A 60-year-old woman trying to discontinue hormone replacement therapy.
Grady
Deborah
D
University of California, San Francisco, 74 New Montgomery St, Suite 600, San Francisco, CA 94105, USA. dgrady@itsa.ucsf.edu
D019386:Alendronate / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D000075202:Contraindications; D003327:Coronary Disease; D003657:Decision Making; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D005348:Fibrocystic Breast Disease; D019584:Hot Flashes; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal; D010052:Ovariectomy; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D020246:Venous Thrombosis
D004966:Estrogens, Conjugated (USP); D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride; D019386:Alendronate